Hughes Stovin syndrome (HSS) is a particularly rare disease characterized by multiple pulmonary artery and/or bronchial artery aneurysms with concomitant peripheral venous thrombosis and is believed to be a cardiovascular variant of Behcet's disease. Intracardiac thrombus occurring as a thrombotic manifestation of HSS is an unusual presentation and represents a challenge in diagnosis and treatment. Here we report a 25-year-old male presenting with recurrent right-sided intracardiac thrombi, in whom pulmonary artery aneurysm was later detected in the clinical course corroborating the diagnosis of HSS and leading to appropriate initiation of immunosuppressive agents. The patient required multiple cardiac surgeries during the clinical course for cardiovascular complications associated with recurrent cardiac thrombus. Unfortunately, the patient was readmitted a year later for massive hemoptysis secondary to pulmonary arterial aneurysm rupture requiring left lower lobectomy. Our case highlights also the significant morbidity, complications, and treatment challenges associated with this potentially life-threatening syndrome, which is intensified in the presence of cardiac involvement.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263413PMC
http://dx.doi.org/10.7759/cureus.7907DOI Listing

Publication Analysis

Top Keywords

hughes stovin
8
stovin syndrome
8
behcet's disease
8
presenting recurrent
8
intracardiac thrombus
8
pulmonary artery
8
clinical course
8
syndrome rare
4
rare form
4
form behcet's
4

Similar Publications

A rare cause of recurrent massive hemoptysis.

Respirol Case Rep

December 2024

Department of Pulmonary Medicine St. John's National Academy of Health Sciences Bengaluru India.

Pulmonary artery aneurysmal rupture is a rare cause of massive hemoptysis. When the suspected origin of bleeding is the pulmonary artery, comprehensive evaluation is necessary to determine aetiology and guide appropriate management. Behçet's disease and Hughes-Stovin Syndrome (HSS) are important differentials to consider after infections and malignancy have been ruled out.

View Article and Find Full Text PDF
Article Synopsis
  • A rare case report discusses a 20-year-old Iranian woman who experienced a ruptured right common iliac aneurysm one year after having deep vein thrombosis (DVT), which was treated with rivaroxaban.
  • The surgical repair was successful, but she faced complications, including abdominal pain, small bowel obstruction, and a large pancreatic pseudocyst, despite ongoing anticoagulant therapy.
  • The report highlights the unusual link between DVT and vascular aneurysms and emphasizes the need to consider potential complications arising from aneurysms when treating DVT in patients.
View Article and Find Full Text PDF

Background: Pulmonary artery trunk aneurysm (PATA) is a rare and complex vascular anomaly characterized by the abnormal dilation of the initial portion of the pulmonary artery, posing significant diagnostic and therapeutic challenges.

Purpose: This clinical case report aims to describe the follow-up of a patient with PATA, emphasizing the role of imaging in diagnosis and monitoring, as well as discussing potential associations with other conditions.

Research Design: The study is designed as a clinical case report, detailing the longitudinal follow-up of a single patient with PATA.

View Article and Find Full Text PDF

Behçet's syndrome (BS) is a rare chronic multisystemic inflammatory disorder of unknown etiopathogenesis. BS is classified as a vasculitis of variable vessel size, which can manifest in both arterial and venous blood vessels. BS commonly presents with mucocutaneous and ocular manifestations.

View Article and Find Full Text PDF
Article Synopsis
  • * A case study describes a 28-year-old man who experienced symptoms like coughing up blood and chest pain, along with complications seen via imaging, initially managed with high-dose corticosteroids and other immunosuppressants.
  • * The patient's condition relapsed after 18 months, but treatment with infliximab (a TNF-alpha inhibitor) led to complete remission, suggesting its potential as an effective second-line therapy for relapsing HSS cases.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!